TCRX

Tscan Therapeutics Inc

Price

$0.18

return (12m)

-84.33%

p/e

-0.20

p/bv

0.34

DIVIDEND YIELD

0.00%

TCRX price

Tscan Therapeutics Inc

If you had invested

exposure

years ago

ago, you would now have *

today you would have:

*The amount considers the reinvestment of dividends.

Return on Investment TCRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-33.67%

3 months

-76.40%

1 year

-84.33%

2 years

-96.80%

5 years

-97.89%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

today you would have:

Fundamentals TCRX

Valuation

P/E

-0.20

Sector 8.00

Industry 8.00

P/BV

0.34

Sector 1.65

Industry 1.65

P/Revenue (PSR)

3.32

Sector 1.65

Industry 1.65

EV/EBITDA

Sector -192,314.88

Industry -192,314.88

EV/EBIT

Sector -38,841,633.98

Industry -38,841,633.98

P/EBITDA

-0.19

Sector 1.35

Industry 1.35

P/EBIT

-0.19

Sector 0.06

Industry 0.06

P/Total Assets

0.14

Sector 0.77

Industry 0.77

P/Net Current Assets

11.98

Sector -1.83

Industry -1.83

P/Working Capital

0.32

Sector -5.08

Industry -5.08

EPS

-0.91

Sector 0.73

Industry 0.73

BVPS

0.53

Sector 10.01

Industry 10.01

Efficiency

Gross Margin

69.30%

Sector 36.30%

Industry 36.30%

EBITDA Margin

-2,755.57%

Sector -48.56%

Industry -48.56%

EBIT Margin

-100.00%

Sector 4.49%

Industry 4.49%

Net Profit Margins

-100.00%

Sector 2.53%

Industry 2.53%

Asset Turnover

0.01

Sector 0.11

Industry 0.11

Profitability

ROE

-95.80%

Sector 3.07%

Industry 3.07%

ROA

-50.09%

Sector -0.43%

Industry -0.43%

ROIC

-83.79%

Sector -1.84%

Industry -1.84%

Dividends

Dividend yield

0.00%

Sector 0.51%

Industry 0.51%

Payout

Sector 10.15%

Industry 10.15%

Debt

Current Ratio

3.37

Sector 1.45

Industry 1.45

Net Debt / EBITDA

Sector -7.06

Industry -7.06

Net Debt / EBIT

Sector -55,330,539.16

Industry -55,330,539.16

Net Debt / Equity

Sector -0.03

Industry -0.03

Gross Debt / Equity

Sector -0.57

Industry -0.57

Equity/Assets

0.40

Sector 0.43

Industry 0.43

Liabilities/Assets

0.60

Sector 0.53

Industry 0.53

Growth

5Y Revenue CAGR

-6.85%

Sector -

Industry -

5Y Earnings CAGR

19.34%

Sector -

Industry -

Fundamentals TCRX

DRAG THE FRAME TO SEE MORE DATA

TCRX - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Tscan Therapeutics Inc

Tscan Therapeutics Inc

Average Investor10 user rating

4.0 (0 people)

United States

- year

Founded:

2021

Time since IPO - 5 years

138

Employees

Tscan Therapeutics Inc (United States) is listed on the Nasdaq and has a market capitalization of $23.60 million, with shareholders equity totaling $69.02 million.

The company employs approximately 138 people and operates in the Others sector, within the Others industry.

Over the past 12 months, Tscan Therapeutics Inc reported $7.11 million in revenue, generating net income of $-117.71 million.

Key financial metrics include a P/E ratio of -0.20, a price-to-book (P/B) ratio of 0.34, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker TCRX.

Market cap

$23.60 million

Net worth

$69.02 million

$69,019,000.00

Assets

$171.45 million

$171,452,000.00

Total Shares Outstanding

129.95 million

129,948,000

Average Daily Trading Volume

$710.13 Thousand

$710,134.00

Sector

Others

Industry

Others

TCRX

TCRX revenue and profits

Financial Results TCRX

DRAG THE FRAME TO SEE MORE DATA

TCRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$395.72 26,33% (12M)

P/E

22.30

2.23%

ROE

16.47%

P/BV

3.52

STLA - Stellantis NV

$4.44 --55,95% (12M)

P/E

-0.52

0.00%

ROE

-35.93%

P/BV

0.19

SHEL - Shell PLC ADR

$100.12 40,93% (12M)

P/E

7.41

2.79%

ROE

22.05%

P/BV

1.54

COR - Cencora Inc.

$339.68 --4,99% (12M)

P/E

24.58

0.72%

ROE

96.34%

P/BV

19.92

TTE - TotalEnergies SE ADR

$88.75 56,07% (12M)

P/E

6.57

4.27%

ROE

25.94%

P/BV

1.59

ALIZY - Allianz SE ADR

$51.98 --6,62% (12M)

P/E

13.51

2.77%

ROE

18.73%

P/BV

2.42

NSRGY - Nestle SA ADR

$106.43 13,70% (12M)

P/E

12.10

3.90%

ROE

60.60%

P/BV

7.33

ELV - Elevance Health Inc

$432.00 40,65% (12M)

P/E

17.74

1.65%

ROE

11.52%

P/BV

2.03